| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |